Cargando…
Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation
Methotrexate (MTX) is a widely used neurotoxic drug with broad antineoplastic and immunosuppressant spectra. However, the exact molecular mechanisms by which MTX inhibits hippocampal neurogenesis are yet unclear. Dexmedetomidine (Dex), an α2-adrenergic receptor agonist, has recently shown neuroprote...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821704/ https://www.ncbi.nlm.nih.gov/pubmed/36614208 http://dx.doi.org/10.3390/ijms24010766 |
_version_ | 1784865762446409728 |
---|---|
author | Taha, Mohamed Eldemerdash, Omar Mohsen Elshaffei, Ismail Mohamed Yousef, Einas Mohamed Senousy, Mahmoud A. |
author_facet | Taha, Mohamed Eldemerdash, Omar Mohsen Elshaffei, Ismail Mohamed Yousef, Einas Mohamed Senousy, Mahmoud A. |
author_sort | Taha, Mohamed |
collection | PubMed |
description | Methotrexate (MTX) is a widely used neurotoxic drug with broad antineoplastic and immunosuppressant spectra. However, the exact molecular mechanisms by which MTX inhibits hippocampal neurogenesis are yet unclear. Dexmedetomidine (Dex), an α2-adrenergic receptor agonist, has recently shown neuroprotective effects; however, its full mechanism is unexplored. This study investigated the potential of Dex to mitigate MTX-induced neurotoxicity and memory impairment in rats and the possible role of the miR-15a/ROCK-1/ERK1/2/CREB/BDNF pathway. Notably, no former studies have linked this pathway to MTX-induced neurotoxicity. Male Sprague Dawley rats were placed into four groups. Group 1 received saline i.p. daily and i.v. on days 8 and 15. Group 2 received Dex at 10 μg/kg/day i.p. for 30 days. Group 3 received MTX at 75 mg/kg i.v. on days 8 and 15, followed by four i.p. doses of leucovorin at 6 mg/kg after 18 h and 3 mg/kg after 26, 42, and 50 h. Group 4 received MTX and leucovorin as in group 3 and Dex daily dosages as in group 2. Bioinformatic analysis identified the association of miR-15a with ROCK-1/ERK1/2/CREB/BDNF and neurogenesis. MTX lowered hippocampal doublecortin and Ki-67, two markers of neurogenesis. This was associated with the downregulation of miR-15a, upregulation of its target ROCK-1, and reduction in the downstream ERK1/2/CREB/BDNF pathway, along with disturbed hippocampal redox state. Novel object recognition and Morris water maze tests demonstrated the MTX-induced memory deficiencies. Dex co-treatment reversed the MTX-induced behavioral, biochemical, and histological alterations in the rats. These neuroprotective actions could be partly mediated through modulating the miR-15a/ROCK-1/ERK1/2/CREB/BDNF pathway, which enhances hippocampal neurogenesis. |
format | Online Article Text |
id | pubmed-9821704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98217042023-01-07 Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation Taha, Mohamed Eldemerdash, Omar Mohsen Elshaffei, Ismail Mohamed Yousef, Einas Mohamed Senousy, Mahmoud A. Int J Mol Sci Article Methotrexate (MTX) is a widely used neurotoxic drug with broad antineoplastic and immunosuppressant spectra. However, the exact molecular mechanisms by which MTX inhibits hippocampal neurogenesis are yet unclear. Dexmedetomidine (Dex), an α2-adrenergic receptor agonist, has recently shown neuroprotective effects; however, its full mechanism is unexplored. This study investigated the potential of Dex to mitigate MTX-induced neurotoxicity and memory impairment in rats and the possible role of the miR-15a/ROCK-1/ERK1/2/CREB/BDNF pathway. Notably, no former studies have linked this pathway to MTX-induced neurotoxicity. Male Sprague Dawley rats were placed into four groups. Group 1 received saline i.p. daily and i.v. on days 8 and 15. Group 2 received Dex at 10 μg/kg/day i.p. for 30 days. Group 3 received MTX at 75 mg/kg i.v. on days 8 and 15, followed by four i.p. doses of leucovorin at 6 mg/kg after 18 h and 3 mg/kg after 26, 42, and 50 h. Group 4 received MTX and leucovorin as in group 3 and Dex daily dosages as in group 2. Bioinformatic analysis identified the association of miR-15a with ROCK-1/ERK1/2/CREB/BDNF and neurogenesis. MTX lowered hippocampal doublecortin and Ki-67, two markers of neurogenesis. This was associated with the downregulation of miR-15a, upregulation of its target ROCK-1, and reduction in the downstream ERK1/2/CREB/BDNF pathway, along with disturbed hippocampal redox state. Novel object recognition and Morris water maze tests demonstrated the MTX-induced memory deficiencies. Dex co-treatment reversed the MTX-induced behavioral, biochemical, and histological alterations in the rats. These neuroprotective actions could be partly mediated through modulating the miR-15a/ROCK-1/ERK1/2/CREB/BDNF pathway, which enhances hippocampal neurogenesis. MDPI 2023-01-01 /pmc/articles/PMC9821704/ /pubmed/36614208 http://dx.doi.org/10.3390/ijms24010766 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Taha, Mohamed Eldemerdash, Omar Mohsen Elshaffei, Ismail Mohamed Yousef, Einas Mohamed Senousy, Mahmoud A. Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation |
title | Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation |
title_full | Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation |
title_fullStr | Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation |
title_full_unstemmed | Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation |
title_short | Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation |
title_sort | dexmedetomidine attenuates methotrexate-induced neurotoxicity and memory deficits in rats through improving hippocampal neurogenesis: the role of mir-15a/rock-1/erk1/2/creb/bdnf pathway modulation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821704/ https://www.ncbi.nlm.nih.gov/pubmed/36614208 http://dx.doi.org/10.3390/ijms24010766 |
work_keys_str_mv | AT tahamohamed dexmedetomidineattenuatesmethotrexateinducedneurotoxicityandmemorydeficitsinratsthroughimprovinghippocampalneurogenesistheroleofmir15arock1erk12crebbdnfpathwaymodulation AT eldemerdashomarmohsen dexmedetomidineattenuatesmethotrexateinducedneurotoxicityandmemorydeficitsinratsthroughimprovinghippocampalneurogenesistheroleofmir15arock1erk12crebbdnfpathwaymodulation AT elshaffeiismailmohamed dexmedetomidineattenuatesmethotrexateinducedneurotoxicityandmemorydeficitsinratsthroughimprovinghippocampalneurogenesistheroleofmir15arock1erk12crebbdnfpathwaymodulation AT yousefeinasmohamed dexmedetomidineattenuatesmethotrexateinducedneurotoxicityandmemorydeficitsinratsthroughimprovinghippocampalneurogenesistheroleofmir15arock1erk12crebbdnfpathwaymodulation AT senousymahmouda dexmedetomidineattenuatesmethotrexateinducedneurotoxicityandmemorydeficitsinratsthroughimprovinghippocampalneurogenesistheroleofmir15arock1erk12crebbdnfpathwaymodulation |